Vascular endothelial growth factor-C in patients with breast cancer

In Vivo

Volumn 21, Issue 3, 2007, Pages 549-552

  Al Mowallad, Abdulfattah ^a   Kirwan, Cliona ^b   Byrne, Gerard ^b   McDowell, Garry ^d   Li, Chenggang ^a   Stewart, Alan ^c   Al Qouzi, Abdullah ^a   Kumar, Shant ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Lymphangiogenesis factor; Metastasis; VEGF C

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; PROGESTERONE; VASCULOTROPIN C;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

EID: 34250211073     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Forbes JF: The incidence of breast cancer: the global burden, public health considerations. Semin Oncol 24: S1-20-S21-35, 1997.
2. Donegan WL: Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47: 28-51, 1997.
3. Nathanson SD: Insights into the mechanisms of lymph node metastasis. Cancer 98: 413-423, 2003.
4. Stacker SA, Baldwin ME and Achen MG: The role of tumor lymphangiogenesis in metastatic spread. Faseb J 16: 922-934, 2002.
5. Duff SE, Li C, Jeziorska M, Kumar S, Saunders MP, Sherlock D, O'Dwyer ST and Jayson GC: Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 89: 426-430, 2003.
6. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K and Detmar M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198, 2001.
7. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K and Harkonen PL: VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98: 946-951, 2002.
8. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Tsukiyama A, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K: Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol 16: 309-314, 2003.
9. Hoar FJ, Chaudhri S, Wadley MS and Stonelake PS: Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. Eur J Cancer 39: 1698-1703, 2003.
10. Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL and Fox SB: The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6: 4278-4286, 2000.
11. Vleugel MM, Bos R, van der Groep P, Greijer AE, Shvarts A, Stel HV, van der Wall E and van Diest PJ: Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol 57: 746-751, 2004.
12. Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K: Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 91: 125-132, 2005.
13. Li Y.S, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K and Inai K: Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast. Pathol Int 56: 256-261, 2006.
14. Al-Mowallad AF, Li C, Wilson P, Duff S, Costello B, Al Qozi A and Kumar S: Quantification of vascular endothelial growth factor-C. J Immunol Methods 289: 239-240, 2004.
15. Williams CS, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL and Jackson DG: Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200: 195-206, 2003.
16. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R and Horvat R: Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240: 306-312, 2004.
17. Cunnick GH, Jiang WG, Gomez KF and Mansel RE: Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. Biochem Biophys Res Commun 288: 1043-1046, 2001.
18. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R and Birner P: VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139: 839-846, 2006.
19. Duff SE, Li C, Renehan A, O'Dwyer ST and Kumar S: Immunodetection and molecular forms of plasma vascular endothelial growth factor-C. Int J Oncol 22: 339-343, 2003.
20. Tamura M and Ohta Y: Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. Cancer 98: 1217-1222, 2003.
21. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K and Sekiya S: Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 103: 724-730, 2005.
22. Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB and Dirix LY: Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 10: 7965-7971, 2004.